Laurie Toich, Associate Editor

Court invalidates patent for abiraterone acetate (Zytiga).

Limited access to gene therapies may impact Americans with rare cancers who live in rural areas.

Inhibiting a specific protein reduces the clinical characteristics of atomic dermatitis.

Significant progress has been made with field of gene therapy over the past few decades.

High-grade cardiovascular adverse events are twice as common when patients with multiple myeloma are treated with carfilzomib.

Controlling cholesterol synthesis expression may reduce walking disability in patients with multiple sclerosis.

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.

Participants in the Transform Rheumatoid Arthritis Care program could save 5% on drug spend.

Greater use of substituting generic drugs could have a major impact on Medicare Part D spending.

Chronochemotherapy plus an p38 MAPK inhibitor may reduce the aggressiveness of glioblastoma cells.

CRSPR-Cas9 technology observed to increase lifespan in mice models of ALS.

Three genes may increase the risk of breast and ovarian cancers in patients with BRCA mutations.

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.

Children with rheumatic diseases may experience treatment variability.

A novel Mcl-1 protein inhibitor may encourage cancer cell apoptosis.

Analytical treatment interruption may not cause long-term damage to patients with HIV.

A transcription factor may contribute to adipose fibrosis and increase the risk of type 2 diabetes among patients with obesity.

There may not be a significant survival benefit from a surgical procedure for gastric cancer.

Median progression-free survival was 5.8 months among patients with HER2-positive gastric cancer who were treated with DS-8201.

Top news of the day from the health care landscape.

Top news of the day from the health care landscape.

Clinical trial data that leads to FDA approvals may be difficult for the general public to understand.

Pembrolizumab (Keytruda) combination therapy may improve outcomes for patients with metastatic non-small cell lung cancer.

The presence of certain bacteria may enhance response to PD-1 inhibitors in melanoma.

Once-weekly pill has the potential to prevent 20% of new HIV infections.

Nearly all people who inject drugs with hepatitis C virus achieved a sustained virologic response at 12 weeks.

Mitochondrial inhibitors may be a beneficial add-on therapy for glioblastoma containing gene fusion.

New research indicates there are distinct subgroups of osteoarthritis that can impact treatment.